RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension

References

• CogolludoAMorenoLVillamorEMechanisms controlling vascular tone in pulmonary arterial hypertension: implications for vasodilator therapyPharmacology200779657517148943
   PubMedGoogle Scholar
• ThenappanTShahSJRichSGomberg-MaitlandMA USA-based registry for pulmonary arterial hypertension: 1982–2006Eur Respir J200730225S230S
   Google Scholar
• OkaMHommaNTaraseviciene-StewartLRho-kinase mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in ratsCirc Res200710092392917332430
   PubMed Web of Science ®Google Scholar
• ShimokawaHTakeshitaARho-kinase is an important therapeutic target in cardiovascular medicineArterioscler Thromb Vasc Biol2005251767177516002741
   PubMed Web of Science ®Google Scholar
• HumbertMSitbonOSimonneauGTreatment of pulmonary hypertensionN Engl J Med20043511425143615459304
   PubMed Web of Science ®Google Scholar
• CoolCDGroshongSDOakeyJVoelkelNFPulmonary hypertension: cellular and molecular mechanismsChest2005128565S571S16373828
   PubMed Web of Science ®Google Scholar
• RunoJRLoydJEPrimary pulmonary hypertensionLancet20033611533154412737878
   PubMed Web of Science ®Google Scholar
• LalichJJMerkowLPulmonary arteritis produced in rats by feeding Crotolaria spectabilisLab Invest19611074475013758395
   PubMed Web of Science ®Google Scholar
• MattocksARToxicity of pirrolizidine alkaloidsNature19982177237285641123
   PubMedGoogle Scholar
• ReidMJLameMWMorinDWilsonDWSegallHJInvolvement of cytochrome P450 3A in the metabolism and covalent bonding of 14C-monocrotaline in rat liver microsomesJ Biochem Toxicol199812157166
   Google Scholar
• LoscalzoJEndothelial dysfunction in pulmonary hypertensionN Engl J Med1992271171191603118
   PubMedGoogle Scholar
• TuderRMGrovesBBadeschDBVoelkelNFExuberant endothelial cell growth and elements of inflammation are present in plexiform lesion of pulmonary hypertensionAm J Pathol19941442752857508683
   PubMed Web of Science ®Google Scholar
• MattocksARDriverHEBarbourRHRobinsDJMetabolism and toxicity of synthetic analogues of macrocyclic diester pyrolizidine alkaloidsChem Biol Interact198658951083708724
   PubMed Web of Science ®Google Scholar
• CampianMEHardziyenkaMMichelMCTanHLHow valid are animal models to evaluate treatments for pulmonary hypertension?Naunyn-Schmeideberg’s Arch Pharmacol2006373391400
   PubMed Web of Science ®Google Scholar
• ReeveJTWagnerWWJrMcMurtryIFGroverRFPhysiological effects of high altitude on the pulmonary circulationInt Rev Physiol197920289310387636
   PubMedGoogle Scholar
• NaejieRMelotCHMoisPHallemansREffects of vasodilators on hypoxic pulmonary vasoconstriction in normal manChest1982824044106811216
   PubMedGoogle Scholar
• MeyrickBReadLThe effect of continuous hypoxia on rat pulmonary arterial circulation: an ultra structural studyLab Invest197838188200146763
   PubMed Web of Science ®Google Scholar
• FungYCLinQChanges of zero-stress state of rat pulmonary arteries in hypoxic hypertensionJ Appl Physiol199170245524701885439
   PubMed Web of Science ®Google Scholar
• WeitzenblumEChauatAHypoxic pulmonary hypertension in man: what minimum daily duration of hypoxaemia is required?Eur Resp J200118251253
   PubMedGoogle Scholar
• ShelubIvan GrondelleAMcCulloughRHofmeisterSReevesJTA model of chronic embolic pulmonary hypertension in dogJ Appl Physiol1984568108156706785
   PubMedGoogle Scholar
• DantzkerDRBowerJSPartial reversibility of chronic pulmonary hypertension caused by thromboembolic diseaseAnn Rev Respir Dis1981124129131
   PubMedGoogle Scholar
• WeimannJZinkWSchnabelPASelective vasodilatation by nitric oxide inhalation during sustained pulmonary hypertension following recurrent microembolism in pigsJ Crit Care19991413314010527251
   PubMedGoogle Scholar
• Taraseviciene-StewartLKasaharaYAlgerLInhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertensionFASEB J20011542743811156958
   PubMed Web of Science ®Google Scholar
• Taraseviciene-StewartLScerbaviciusRChoeKHSimvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertensionAm J Physiol Lung Cell Mol Physiol2006291L668L67616698853
   PubMed Web of Science ®Google Scholar
• VoelkelNFTuderRMHypoxia-induced pulmonary vascular remodeling: a model for what human disease?J Clin Invest200010673373810995781
   PubMedGoogle Scholar
• LaneKBMachadoRDPauciuloMWHeterozygous germline mutation in BMPR2, encoding a TGF-beta receptor, causing familial primary pulmonary hypertension. The international PPH ConsortiumNat Genet200026818410973254
   PubMed Web of Science ®Google Scholar
• DengZMorseJHSlagerSLFamilial primary pulmonary hypertension (gene PPH1) is caused by mutation in the bone morphogenetic protein receptor-II geneAm J Hum Genet20046773774410903931
   PubMedGoogle Scholar
• BeppuHKawabataMHamamotoTBMP type II receptor is required for gastrulation and early development of mouse embryosDev Biol200022124925810772805
   PubMedGoogle Scholar
• EddahibiSHanounNLanfumeyLAttenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine B11 transporter geneJ Clin Invest20001051555156210841514
   PubMed Web of Science ®Google Scholar
• EddahibiSHumbertMFadelESerotonin transporter over-expression is responsible for pulmonary artery smooth muscle hyperplasia in primary pulmonary hypertensionJ Clin Invest20011081141115011602621
   PubMed Web of Science ®Google Scholar
• FrostellCFratacciMDWainJCJonesRZapolWMInhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstrictionCirculation199183203820472040056
   PubMed Web of Science ®Google Scholar
• Pepke-ZabaJHiggenbottamTWDinh-XuanATStoneDWallworkJInhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertensionLancet1991338117311741682593
   PubMed Web of Science ®Google Scholar
• AdatiaIThompsonJLandzbergMWesselDLInhaled nitric oxide in chronic obstructive lung diseaseLancet19933413073088093943
   PubMedGoogle Scholar
• RossaintRFalkeKJLopezFSlamaKPisonUZapolWMInhaled nitric oxide for the adult respiratory distress syndromeN Engl J Med19933283994058357359
   PubMed Web of Science ®Google Scholar
• McIntyreRCJrMooreFAMooreEEPiedalueFHaenalJSFullerttonDAInhaled nitric oxide variably improves oxygenation and pulmonary hypertension in patients with acute respiratory distress syndromeJ Trauma1995394184257473902
   PubMed Web of Science ®Google Scholar
• FrostellCGBlomqvistHHedenstiernaGLundbergJZapolWMInhaled nitric oxide selectively reverses human hypoxic pulmonary vasoconstriction without causing systemic vasodilationAnesthesiology1993784274358457043
   PubMed Web of Science ®Google Scholar
• WalmrathDSchneiderTSchermulyROlschewskiHGrimmingerFSeegerWDirect comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndromeAm J Respir Crit Care Med19961569919968630585
   PubMedGoogle Scholar
• GerlachHRossaintRPappertDFalkeKJTime-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndromeEur J Clin Invest1993234995028405003
   PubMed Web of Science ®Google Scholar
• GowAJThomSRIschiropoulosHNitric oxide and peroxynitrite-mediated pulmonary cell deathAm J Physiol1998274L112L1189458808
   PubMed Web of Science ®Google Scholar
• McLaughlinVVRichSPulmonary hypertension-advances in medical and surgical interventionJ Heart Lung Transplant1998177397439730421
   PubMedGoogle Scholar
• WanstallJCJeffreyTKRecognition and management of pulmonary hypertensionDrugs19985698910079878988
   PubMed Web of Science ®Google Scholar
• RichSMcLaughlinVVThe effect of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertensionJ Am Coll Cardiol1999341184118710520810
   PubMed Web of Science ®Google Scholar
• WittWMullerBAntithrombotic profile of iloprost in experimental models of in vivo platelet aggregation and thrombosisAdv Prostaglandin Thromboxane Leuktriene Res198717A279284
   PubMedGoogle Scholar
• SajiTOzawaYIshikitaTMatsuuraHMatsuoNShort-term hemodynamic effect of a new oral PGI2 analogue, beraprost, in primary and secondary pulmonary hypertensionAm J Cardiol1996782442478712155
   PubMed Web of Science ®Google Scholar
• HashidaHHamadaMShigematsuYBeneficial hemodynamic effect of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension: a case reportAngiology1998491611649482517
   PubMedGoogle Scholar
• ArcherSJMichelakisEDAn evidence-based approach to the management of pulmonary arterial hypertensionCurr Opin Cardiol20062138539216755209
   PubMedGoogle Scholar
• MiyauchiTYorikaneRSakaiSContribution of endogenous endothelin-1 to the progression of cardiopulmonary alteration in rats with monocrotaline-induced pulmonary hypertensionCirc Res1993738878978403258
   PubMed Web of Science ®Google Scholar
• ChenSChenYMengQCDurandJDicarloVSOparilSEndothelin-receptor antagonist bosentan prevents and reverses hypoxic pulmonary hypertension in ratsJ Appl Physiol199579212221318847282
   PubMed Web of Science ®Google Scholar
• HillNSWarburtonRRPietrasLKlingerJRNon-specific endothelin-receptor antagonists blunt monocrotaline-induced pulmonary hypertension in ratsJ Appl Physiol199783120912159338430
   PubMed Web of Science ®Google Scholar
• ChannickRNSimonneauGSitbonOEffects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomized placebo-controlled studyLancet20013581119112311597664
   PubMed Web of Science ®Google Scholar
• RubinLJBadeschDBBarstRJBosentan therapy for pulmonary arterial hypertensionN Engl J Med200234689690311907289
   PubMed Web of Science ®Google Scholar
• ZhaoLMasonNAMorrellNWSildenafil inhibits hypoxia-induced pulmonary hypertensionCirculation200110442442811468204
   PubMed Web of Science ®Google Scholar
• RichaletJPGratadourPRobachPSildenafil inhibits altitude-induced hypoxemia and pulmonary hypertensionAm J Respir Crit Care Med200517127528115516532
   PubMed Web of Science ®Google Scholar
• WilkinsMRPaulGAStrangeJWSildenafil versus endothelin receptor antagonist for pulmonary hypertension (SERAPH) studyAm J Respir Crit Care Med20051711292129715750042
   PubMed Web of Science ®Google Scholar
• IkedaDTsujimoIOhiraHAddition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertensionJ Cardiovasc Pharmacol20054528628915772514
   PubMed Web of Science ®Google Scholar
• NagayaNYokoyamaCKyotaniSGene transfer of human prostacyclin synthase ameliorates monocrotaline-induced pulmonary hypertension in ratsCirculation20001022005201211034952
   PubMed Web of Science ®Google Scholar
• Schulze-NieckILutherYCEwertPLehmkuhlHBHetzerRLangePEEnd-stage heart failure with pulmonary hypertension: levosimendan to evaluate for heart transplantation alone versus combined heart-lung transplantationTransplantation2004781237123815502728
   PubMedGoogle Scholar
• SitbonOHumbertMJaisXLong-term response to calcium channel blockers in idiopathic pulmonary arterial hypertensionCirculation20051113105311115939821
   PubMed Web of Science ®Google Scholar
• ShimokawaHRho-kinase as a novel therapeutic target in treatment of cardiovascular diseasesJ Cardiovasc Pharmacol20023931932711862109
   PubMed Web of Science ®Google Scholar
• FukomotoYTawaraSShimokawaHRecent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitorsTohuku J Exp Med2007211309320
   PubMedGoogle Scholar
• LoirandGGuerinPPacaudPRho kinases in cardiovascular physiology and pathophysiologyCirc Res20069832233416484628
   PubMed Web of Science ®Google Scholar
• LiFXiaWLiAZhaoCSunRLong-term inhibition of Rho kinase fasudil attenuates high flow induced pulmonary artery remodeling in ratsPharmacol Res200755647117127075
   PubMed Web of Science ®Google Scholar
• FukomotoYMatobaTItoAAcute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertensionHeart20059139139215710736
   PubMedGoogle Scholar
• ShimokawaHTakeshitaARho-kinase is an important therapeutic target in cardiovascular medicineArterioscler Thromb Vasc Biol2005251767177516002741
   PubMed Web of Science ®Google Scholar
• RidleyAJHallAThe small GTP-binding protein rho regulates the assembly of focal adhesions and actin stress fibers in response to growth factorsCell1992703893991643657
   PubMed Web of Science ®Google Scholar
• SomlyoAPSomlyoAVCa2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatasePhysiol Rev2003831325133814506307
   PubMed Web of Science ®Google Scholar
• GongMCLizukaKNixonGRole of guanine nucleotide-binding proteins-ras-family or trimeric proteins or both-in Ca2+ sensitization of smooth muscleProc Soc Natl Sci USA19969313401345
   PubMedGoogle Scholar
• HirataKKikuchiASasakiTInvolvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contractionJ Biol Chem1992267871987221577714
   PubMed Web of Science ®Google Scholar
• IshizakiTMaekawaMFujikawaKThe small GTP-binding protein Rho binds to activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinaseEMBO J199615188518938617235
   PubMed Web of Science ®Google Scholar
• KaibuchiKKurodaSAmanoMRegulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cellsAnn Rev Biochem19996845948610872457
   PubMed Web of Science ®Google Scholar
• KimuraKItoMAmanoMRegulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase)Science19962732452488662509
   PubMed Web of Science ®Google Scholar
• GongMCFujiharaHSomlyoAVSomlyoAPTranslocation of rhoA associated with Ca2+ sensitization of smooth muscleJ Biol Chem199727210704107099099720
   PubMed Web of Science ®Google Scholar
• OttoBSteusloffAJustIAktoriesKPfitzerGRole of Rho proteins in carbachol-induced contractions in intact and permeabilized guinea-pig intestinal smooth muscleJ Physiol19964963173298910218
   PubMedGoogle Scholar
• UehataMIshizakiTSatohHCalcium sensitization of smooth smooth muscle mediated by a Rho-associated protein kinase in hypertensionNature19973899909949353125
   PubMed Web of Science ®Google Scholar
• YoshiiALizukaKDobashiKRelaxation of contracted rabbit tracheal and human bronchial smooth muscle by Y-27632 through inhibition of Ca2+ sensitizationAm J Respir Cell Moll Biol19992011901200
   PubMedGoogle Scholar
• MuellerBKMackHTeuschNRho kinase, a promising drug target for neurological disordersNat Rev20054387398
   Google Scholar
• NagaokaTMorioYCasanovaNRho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic ratsAm J Physiol Lung Cell Mol Physiol2004287L665L67212959926
   PubMed Web of Science ®Google Scholar
• FaganKAOkaMBauerNRAttenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinaseAm J Physiol Lung Cell Mol Physiol2004287L656L66414977625
   PubMed Web of Science ®Google Scholar
• KnockGASnetkovVAShaiftaYSuperoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca2+ sensitizationFree Rad Biol Med20094663364219103285
   PubMedGoogle Scholar
• WilsonDPSusnjarMKissESutherlandCWalshMPThromboxane A2 –induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+ sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855, but not Thr-697Biochem J200538976377415823093
   PubMedGoogle Scholar
• WangZJinNGanguliSSwartzDRLiLRhoadesRARho-kinase activation is involved in hypoxia-induced pulmonary vasoconstrictionAm J Respir Cell Mol Biol20012562863511713106
   PubMed Web of Science ®Google Scholar
• BaillyKRidleyAJHallSMHaworthSGRhoA activation by hypoxia in pulmonary arterial smooth muscle cells is age and site specificCirc Res2004941383139115087418
   PubMed Web of Science ®Google Scholar
• RobertsonTPDippMWardJPAaronsonPIEvansAMInhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intra-pulmonary arteries and perfused lung of the ratBr J Pharmacol20001315910960061
   PubMed Web of Science ®Google Scholar
• HyvelinJMHowellKNicholACostelloCMPrestonRJMcLoughlinPInhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulationCirc Res20059718519115961717
   PubMedGoogle Scholar
• McNamaraPJMurthyPKantoresCAcute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxideAm J Physiol Lung Cell Mol Physiol2008294L205L21318032699
   PubMed Web of Science ®Google Scholar
• BarmanSAVasoconstrictor effect of endothelin-1 in hypertensive pulmonary arterial smooth muscle involves Rho kinase and protein kinase CAm J Physiol2007293L472L479
   Google Scholar
• WeigandLSylvesterJTShimodaLAMechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic ratsAm J Physiol Lung Cell Mol Physiol2006290L284L29016155085
   PubMedGoogle Scholar
• BroughtonWalkerBRRestaTCChronic hypoxia induces Rho-kinase dependent myogenic tone in small pulmonary arteriesAm J Physiol Lung Cell Mol Physiol2008294797806
   Web of Science ®Google Scholar
• NagaokaTFaganKAGebbSAInhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertensionAm J Respir Crit Care Med200517149449915563635
   PubMed Web of Science ®Google Scholar
• GuilluyCRolli-DerkinderenMTharauxP-LMelinoGPacaudPLoirandGTransglutaminase-dependent RhoA activation and depletion by serotonin in vascular smooth muscle cellsJ Biol Chem20072822918292817142836
   PubMed Web of Science ®Google Scholar
• WaltherDJPeterJUWinterSSerotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule releaseCell200311585186214697203
   PubMed Web of Science ®Google Scholar
• HemnesARWigleyFRodriguesFWPulmonary hypertension is associated with increased expression and activity of phosphodiesterase type 5ACirculation2005112II-221II-222
   Google Scholar
• ShimokawaHSetoMKatsumataNRho-kinase-mediated pathway induces enhanced myosin light chain phosphorylation in a swine model of coronary artery spasmCardiovasc Res1999431029103910615430
   PubMed Web of Science ®Google Scholar
• KatsumataNShimokawaHSetoMEnhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1betãCirculation199796435743639416904
   PubMedGoogle Scholar
• ShimokawaHHiramoriKLinumaHAntianginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: a multicenter studyJ Cardiovasc Pharmacol20023931932711862109
   PubMed Web of Science ®Google Scholar
• ShimokawaHRashidMDevelopment of Rho-kinase inhibitors for cardiovascular medicineTrends Pharmacol Sci20072829630217482681
   PubMed Web of Science ®Google Scholar
• OkaMFaganKAJonesPLMcMurtryTherapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertensionBr J Pharmacol200815544445418536743
   PubMed Web of Science ®Google Scholar
• ChapadosRAbeKIheda-StansburyKROCK controls matrix synthesis in vascular smooth muscle cells: coupling vasoconstriction to vascular remodelingCirc Res20069983784416990566
   PubMed Web of Science ®Google Scholar
• AbeKShimokawaHMorikawaKLong-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertensionCirc Res20049438539314670839
   PubMed Web of Science ®Google Scholar
• AbeKTawaraSOiKLong-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in miceJ Cardiovasc Pharmacol20064828028517204906
   PubMedGoogle Scholar
• NomaKOyamaNLiaoJKPhysiological role of ROCKs in the cardiovascular systemAm J Physiol Cell Physiol2006290C661C66816469861
   PubMed Web of Science ®Google Scholar
• NishimuraTVaszarLTFaulJLSimvastatin rescues rats from fatal pulmonary hypertension by inducing apoptosis of neointimal smooth muscle cellsCirculation20031081640164512963647
   PubMed Web of Science ®Google Scholar
• LeeJHLeeDSKimEKSimvastatin inhibits cigarette smoking-induced emphysema and pulmonary hypertension in rat lungsAm J Resp Crit Care Med200517298799316002570
   PubMed Web of Science ®Google Scholar
• MurataTKinoshitaKHoriMStatin protects endothelial nitric oxide synthase activity in hypoxia-induced pulmonary hypertensionArterioscler Thromb Vasc Biol2005252335234216166567
   PubMed Web of Science ®Google Scholar
• GuerardPRakotoniainaZGoirandFThe HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOSNaunyn Schmeidebergs Arch Pharmacol2006373401414
   PubMed Web of Science ®Google Scholar
• LaudiSTrumpSSchmitzVSerotonin transporter protein in pulmonary hypertensive rats treated with atorvastatinAm J Lung Cell Mol Physiol2007293L630L638
   PubMed Web of Science ®Google Scholar
• GirgisREMozammelSChampionHCRegression of chronic hypoxic pulmonary hypertension by simvastatinAm J Lung Cell Mol Physiol2007292L1105L1110
   PubMed Web of Science ®Google Scholar
• LiMLiuYDuttPFanburgBLToksozDInhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatinAm J Lung Cell Mol Physiol2007293L463L471
   PubMedGoogle Scholar
• IshikuraKYamadaNItoMBeneficial acute effects of rho-kinase inhibitor in patients with pulmonary arterial hypertensionCirc J20067017417816434811
   PubMed Web of Science ®Google Scholar
• MohriMShimokawaHHirakawaYMasumotoATakeshitaARho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasmJ Am Coll Cardiol200341151912570938
   PubMed Web of Science ®Google Scholar